Cargando…
Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome
The primary anti-phospholipid syndrome (APS) is characterized by the production of antibodies that bind the phospholipid-binding protein β2 glycoprotein I (β2GPI) or that directly recognize negatively charged membrane phospholipids in a manner that may contribute to arterial or venous thrombosis. Cl...
Autores principales: | Radic, Marko, Pattanaik, Debendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949565/ https://www.ncbi.nlm.nih.gov/pubmed/29867951 http://dx.doi.org/10.3389/fimmu.2018.00969 |
Ejemplares similares
-
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
por: Borghi, Maria Orietta, et al.
Publicado: (2020) -
A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome
por: Truglia, Simona, et al.
Publicado: (2018) -
Pathogenesis of Systemic Sclerosis
por: Pattanaik, Debendra, et al.
Publicado: (2015) -
Editorial: New roles of neutrophils and granulocytic MDSC in autoimmune diseases, inflammation, and anti-microbial immunity
por: Odobasic, Dragana, et al.
Publicado: (2022) -
Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)